Dr Kaveri Joshi

Dr. Kaveri Joshi

Consultant Immuno Haematologist-Uppal Neuro Hospital

Dr. Kaveri Joshi is an Immuno Haematogologist with experience in clinical haematology from DMCH, Ludhiana, MBBS from AIMSR, Bathinda in  2019, MD IHBT from DMC 2023 passout, Sr. Ship American Oncology Institute DMC, Ludhiana, 2025.

Research experience:

  • Thesis dissertation- Blood Transfusion in Neonates

Posters:

  • Clinical determinants and pattern of blood and blood components transfusion in neonatesPresented at Transmedcon 2021, Guwahati

  • Low toxicity and meaningful progression free survival benefit with autologous stem cel transplantation across the spectrum of plasma cel dyscrasias: A single centre experiencePresented at HCC 2022

  • Clinical characteristics and prospective follow up of Indian patients with BCR: ABL1 negative myeloproliferative neoplasms: Low symptom burden and rates of thrombosis

Publications

  • 1-Monoclonal gammopathy of unknown significance: Implications of Indian baseline data:THE NATIONAL MEDICAL JOURNAL OF INDIA VOL. 34, NO. 6, 2021

  • Risk of cardiovascular events after combined modality therapy for early-stage favorable Hodgkin’s lymphoma: Low but not zero:Cancer Research, Statistics, and Treatment / Volume 4 / Issue 4 / October-December 2021 

  • Transplantation and maintenance in multiple myeloma appear to overcome differences in induction regimens:Cancer Research, Statistics, and Treatment /Volume 5/ Issue 1/January-March 2022

  • Distinctive Attributes of Indian Patients with Classical BCR: ABL1 Negative Myeloproliferative Neoplasms: Unified Clinical and Laboratory Data:Clinical Lymphoma, Myeloma and Leukemia,2023 Elsevier Inc.

  • Platelet transfusion threshold before central line insertion: An elusive yardstick?:The National Medical Journal of India.

  • Objective assessment of ChatGPT in hematology-oncology manuscript composition: Balancing promise with factual inaccuracies:June CRST

  • Clinical and Renal Outcomes in Multiple Myeloma with Involved Free Light Chains Exceeding 1000 mg/L at Diagnosis: Insights from an Indian cohort

    Journal: Clinical Lymphoma, Myeloma and Leukemia

Posters

  • 1-Clinical determinants and pattern of blood and blood components transfusion in neonates:Presented at Transmedcon 2021, Guwahati

  • Low toxicity and meaningful progression free survival benefit with autologous stem cel transplantation across the spectrum of plasma cel dyscrasias: A single centre experience:Presented at HCC 2022

  • Clinical characteristics and prospective follow up of Indian patients with BCR: ABL1 negative myeloproliferative neoplasms: Low symptom burden and rates of thrombosis:Presented at HCC 2022

Oral Presentation:

  • Role of TPE in neuropsychiatric manifestation of SLE Presented at Transmedcon 2022, Indore